Showing results 10 to 21 of 21
< previous
Issue Date | Title | Author(s) |
2016-01-01 | Measuring delirium point-prevalence in two Australian palliative care inpatient units | Hosie, A; Lobb, E; Agar, M; Davidson, P; Chye, R; Lam, L; Phillips, J |
2019-04 | Monitoring quality of care for patients with pancreatic cancer: a modified Delphi consensus. | Maharaj, AD; Ioannou, L; Croagh, D; Zalcberg, J; Neale, RE; Goldstein, D; Merrett, N; Kench, JG; White, K; Pilgrim, CHC; Chantrill, L; Cosman, P; Kneebone, A; Lipton, L; Nikfarjam, M; Philip, J; Sandroussi, C; Tagkalidis, P; Chye, R; Haghighi, KS; Samra, J; Evans, SM |
2019-01-01 | Multicomponent non-pharmacological intervention to prevent delirium for hospitalised people with advanced cancer: Study protocol for a phase II cluster randomised controlled trial | Hosie, A; Phillips, J; Lam, L; Kochovska, S; Noble, B; Brassil, M; Kurrle, SE; Cumming, A; Caplan, GA; Chye, R; Le, B; Ely, EW; Lawlor, PG; Bush, SH; Davis, JM; Lovell, M; Brown, L; Fazekas, B; Cheah, SL; Edwards, L; Agar, M |
2015-01-01 | Nurse perceptions of the Nursing Delirium Screening Scale in two palliative care inpatient units: A focus group study | Hosie, A; Lobb, E; Agar, M; Davidson, PM; Chye, R; Phillips, J |
2022-10 | Paracentesis for cancer-related ascites in palliative care: An international, prospective cohort study. | Seah, DS; Wilcock, A; Chang, S; Sousa, MS; Sinnarajah, A; Teoh, CO; Allan, S; Chye, R; Doogue, M; Hunt, J; Agar, M; Currow, DC |
2015-01-01 | Pharmacovigilance in hospice/palliative care: Net effect of gabapentin for neuropathic pain | Sanderson, C; Quinn, SJ; Agar, M; Chye, R; Clark, K; Doogue, M; Fazekas, B; Lee, J; Lovell, MR; Rowett, D; Spruyt, O; Currow, DC |
2016-09-01 | Pharmacovigilance in hospice/palliative care: Net effect of pregabalin for neuropathic pain | Sanderson, C; Quinn, SJ; Agar, M; Chye, R; Clark, K; Doogue, M; Fazekas, B; Lee, J; Lovell, MR; Rowett, D; Spruyt, O; Currow, DC |
2011-11-01 | A retrospective analysis of primary diagnosis, comorbidities, anticholinergic load, and other factors on treatment for noisy respiratory secretions at the end of life | Sheehan, C; Clark, K; Lam, L; Chye, R |
2021-06-28 | Study protocol for SKIPMDD: subcutaneous ketamine infusion in palliative care patients with advanced life limiting illnesses for major depressive disorder (phase II pilot feasibility study). | Lee, W; Sheehan, C; Chye, R; Chang, S; Loo, C; Draper, B; Agar, M; Currow, DC |
2023 | Subcutaneous ketamine infusion in palliative patients for major depressive disorder (SKIPMDD)-Phase II single-arm open-label feasibility study. | Lee, W; Sheehan, C; Chye, R; Chang, S; Bayes, A; Loo, C; Draper, B; Agar, MR; Currow, DC; Akena, D |
2003-08-01 | Treatment of recurrent aspiration pneumonia in end-stage dementia: Preferences and choices of a group of elderly nursing home residents | Low, JA; Chan, DKY; Hung, WT; Chye, R |
2019-03 | Understanding transdermal buprenorphine and a practical guide to its use for chronic cancer and non-cancer pain management. | O'Brien, T; Ahn, JS; Chye, R; Le, B; Lu, H; Olarte, G; Palladini, M; Salti, A; Shao, Y-Y; Yaakup, H; Buemio, KC; Colin, CG; Hadjiat, Y |